http://altimmune.com
Altimmune, Inc. Company Intro
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Industry
Healthcare
Altimmune, Inc. Headquaters
910 Clopper Road
Gaithersburg,20878
United States
Altimmune, Inc. Share price
14 Sep 2022 08:35 GMT
$19.85
-0.61 (-2.98 %)
Altimmune, Inc. Market cap
$999.136 M
WMC RANKING
2022
Altimmune, Inc. # 201
BiotechnologyLatest Altimmune, Inc. News
26 Nov 2022
Altimmune Inc. (ALT) Is Touching $9.09: At This Price, The ...
Altimmune Inc. (NASDAQ:ALT) concluded the trading at $9.09 on Friday, November 25, with a fall of -1.84% from its closing price on previous day.
26 Nov 2022
Altimmune Inc. (ALT) Is Touching $9.09: At This Price, The ...
Altimmune Inc. (NASDAQ:ALT) concluded the trading at $9.09 on Friday, November 25, with a fall of -1.84% from its closing price on previous day.
26 Nov 2022
Altimmune Inc. (ALT) Is Touching $9.09: At This Price, The ...
Altimmune Inc. (NASDAQ:ALT) concluded the trading at $9.09 on Friday, November 25, with a fall of -1.84% from its closing price on previous day.
WMC Market Score
WMC Market to Revenue Score
Altimmune, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Altimmune, Inc. | USD | $6,810 | $69,164 | $-60,023 | $9,991M | 201 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Altimmune, Inc. Social Followers vs Top 4 Industry Competitors
Altimmune, Inc. Post vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Altimmune, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Altimmune, Inc. | 0.07 | 1.30 | 0.00 | 0 | 0 | 0 | 0.59 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
